Abstract
Transdermal formulation of L-ascorbic acid 2-phosphate magnesium salt (A2P) was prepared using multilamellar vesicles (MLV). A2P was either physically mixed with or entrapped into three different MLVs of neutral, cationic, and anionic liposome vesicles. For the preparation of neutral MLVs, phosphatidylcholine (PC) and cholesterol (CH) were used. For cationic and anionic MLVs, dioleoyl-trimethylammonium-propane and dimyristoyl glycerophosphate were added as surface charge inducers, respectively, in addition to PC and CH. Particle size of the three A2P-loaded MLVs was submicron, and polydispersity index revealed homogenous distribution of the prepared MLVs except neutral ones. Skin penetration study with hairless mouse skin showed that both physical mixtures of A2P with empty MLVs and A2P-loaded MLVs increased penetration of the drug compared to aqueous A2P solution. During the penetration, however, significant amount of the drug was metabolized into L-ascorbic acid, which has no beneficial effect on stimulation of hair growth. Out of the physical mixtures and A2P-loaded MLVs tested, physical mixture of A2P with empty cationic MLV resulted in the greatest skin penetration and retention in hairless mouse skin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ciotti, S. N. and Weiner, N., Follicular liposomal delivery systems. J. Liposome Res., 12, 143–148 (2002).
Elsayed, M. M., Abdallah, O. Y., Naggar, V. F., and Khalafallah, N. M., PG-liposomes: novel lipid vesicles for skin delivery of drugs. J. Pharm. Pharmacol., 59, 1447–1450 (2007a).
Elsayed, M. M., Abdallah, O. Y., Naggar, V. F., and Khalafallah, N. M., Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int. J. Pharm., 332, 1–16 (2007b).
Hata, R. and Senoo, H., L-ascorbic acid 2-phosphate stimulates collagen accumulation, cell proliferation, and formation of a three-dimensional tissuelike substance by skin fibroblasts. J. Cell. Physiol., 138, 8–16 (1989).
Kramers, M. T., Catovsky, D., and Foa, R., Cell membrane enzymes II: Alkaline phosphatase and alkaline phosphodiesterase I in normal and leukaemic lymphocytes. Br. J. Haematol., 40, 111–118 (1978).
Merclin, N., Bender, J., Sparr, E., Guy, R. H., Ehrsson, H., and Engstrom, S., Transdermal delivery from a lipid sponge phase: iontophoretic and passive transport in vitro of 5-aminolevulinic acid and its methyl ester. J. Control. Rel., 100, 191–198 (2004).
Norwood, O. T., Male pattern baldness: classification and incidence. South. Med. J., 68, 1359–1365 (1975).
Piemi, M. P., Korner, D., Benita, S., and Marty, J. P., Positively and negatively charged submicron emulsions for enhanced topical delivery of antifungal drugs. J. Control. Rel., 58, 177–187 (1999).
Rojanasakul, Y., Wang, L. Y., Bhat, M., Glover, D. D., Malanga, C. J., and Ma, J. K., The transport barrier of epithelia: a comparative study on membrane permeability and charge selectivity in the rabbit. Pharm. Res., 9, 1029–1034 (1992).
Sung, Y. K., Hwang, S. Y., Cha, S. Y., Kim, S. R., Park, S. Y., Kim, M. K., and Kim, J. C., The hair growth promoting effect of ascorbic acid 2-phosphate, a long-acting vitamin C derivative. J. Dermatol. Sci., 41, 150–152 (2006).
Takamizawa, S., Maehata, Y., Imai, K., Senoo, H., Sato, S., and Hata, R., Effects of ascorbic acid and ascorbic acid 2-phosphate, a long-acting vitamin C derivative, on the proliferation and differentiation of human osteoblast-like cells. Cell Biol. Int., 28, 255–265 (2004).
Verma, D. D., Verma, S., Blume, G., and Fahr, A., Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study. Eur. J. Pharm. Biopharm., 55, 271–277 (2003).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yoo, J., Shanmugam, S., Song, CK. et al. Skin penetration and retention of L-Ascorbic acid 2-phosphate using multilamellar vesicles. Arch. Pharm. Res. 31, 1652–1658 (2008). https://doi.org/10.1007/s12272-001-2164-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-001-2164-4